2024/10/04 17:20:00 | |
---|---|
Price | |
862.60 DKK | |
Difference | -1.42% (-12.40) |
ISIN | DK0060448595 |
Symbol | COLO B |
Exchange | Nasdaq Copenhagen |
Currency | DKK |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,917 EUR |
Benchmark | OMX COPENHAGEN 20 |
Bid (Bid size) | 862.40 DKK (44) |
Ask (Ask size) | 862.80 DKK (68) |
Open | 873.20 DKK |
High | 877.20 DKK |
Low | 860.20 DKK |
Close (prev. day) | 875.00 DKK |
VWAP | 864.0609 DKK |
Volume (pcs) | 112,072 |
Trading volume | 96,849,517.70 |
Number of trades | 1,550 |
Last size | - |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/10/27 | Global Equity Ratings | ||
2023/09/29 | Global Equity Ratings | ||
2023/09/08 | Global Equity Ratings | ||
2023/08/22 | Global Equity Ratings | ||
2023/08/17 | Global Equity Ratings |
2024/10/04 17:20:00 | |
---|---|
Price | |
862.60 DKK | |
Difference | -1.42% (-12.40) |
ISIN | DK0060448595 |
Symbol | COLO B |
Exchange | Nasdaq Copenhagen |
Currency | DKK |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,917 EUR |
Benchmark | OMX COPENHAGEN 20 |
Bid (Bid size) | 862.40 DKK (44) |
Ask (Ask size) | 862.80 DKK (68) |
Open | 873.20 DKK |
High | 877.20 DKK |
Low | 860.20 DKK |
Close (prev. day) | 875.00 DKK |
VWAP | 864.0609 DKK |
Volume (pcs) | 112,072 |
Trading volume | 96,849,517.70 |
Number of trades | 1,550 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -4.46% | +19.21% | -12.18% |
Perf (abs.) | -5.45 | +18.82 | -16.20 |
Beta | 0.12 | 0.27 | 0.55 |
Volatility | 23.26 | 26.80 | 27.75 |
Ø price 5 days | Ø volume 5 days (pcs.) | 873.00 DKK (133,861) |
Ø price 30 days | Ø volume 30 days (pcs.) | 904.99 DKK (175,565) |
Ø price 100 days | Ø volume 100 days (pcs.) | 877.45 DKK (193,514) |
Ø price 250 days | Ø volume 250 days (pcs.) | 846.49 DKK (208,230) |
YTD High | date | 977.60 DKK (2024/03/12) |
YTD Low | date | 757.80 DKK (2024/01/05) |
52 Weeks High | date | 977.60 DKK (2024/03/12) |
52 Weeks Low | date | 689.20 DKK (2023/11/10) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/04 | 17:35 | 116.85 EUR | 0.02 | 7 |
Vienna Stock Exchange | 2024/10/04 | 17:32 | 116.25 EUR | 0.00 | 5 |
Tradegate | 2024/10/04 | 22:26 | 116.55 EUR | 0.14 | 22 |
Stuttgart | 2024/10/04 | 08:10 | 117.15 EUR | 0.00 | 3 |
SIX Swiss Exchange | 2020/04/09 | 17:36 | 111.00 CHF | 0.00 | 1 |
Nasdaq Copenhagen | 2024/10/04 | 17:20 | 862.60 DKK | 96.85 | 1,550 |
Munich | 2024/10/04 | 08:05 | 117.70 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/10/04 | 16:55 | 864.80 DKK | 0.00 | 8 |
Hanover | 2024/10/04 | 17:25 | 116.05 EUR | 0.00 | 3 |
Frankfurt | 2024/10/04 | 11:17 | 117.00 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/10/01 | 20:55 | 126.26 USD | 0.00 | 1 |
Duesseldorf | 2024/10/04 | 19:30 | 116.05 EUR | 0.00 | 5 |
Berlin | 2024/10/04 | 21:52 | 116.75 EUR | 0.00 | 16 |
COLOPLAST A/S |
- - |
Holtedam 1-3 - 3050 Humlebaek |
Telefon: +45-49-11-11-11 |
Fax: + |
E-mail: - |
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark. |
Kristian Villumsen | Chairman of Managing Board |
Allan Rasmussen | Member of Executive Committee |
Anders Lonning-Skovgaard | Member of Executive Committee |
Dorthe Ronnau | Member of Executive Committee |
Nicolai Buhl Andersen | Member of Executive Committee |
Paul Marcun | Member of Executive Committee |
Lars Søren Rasmussen | Chairman of Supervisory Board |
Annette Brüls | Member of Supervisory Board |
Carsten Hellmann | Member of Supervisory Board |
Jette Nygaard-Andersen | Member of Supervisory Board |
Marianne Wiinholt | Member of Supervisory Board |
Niels Peter Louis-Hansen | Member of Supervisory Board |
Nikolaj Kyhe Gundersen | Member of Supervisory Board |
Roland Vendelbo Pedersen | Member of Supervisory Board |
Thomas Barfod | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer